Table 2.
Cancer | Disease progression | Positive rate |
---|---|---|
Laryngeal carcinoma (122) | 10mm incision margin of supraglottic carcinoma | 22.20% |
5mm incision margin of supraglottic carcinoma | 50.90% | |
Supraglottic carcinoma | 91.30% | |
10mm incision margin of hypopharyngeal carcinoma | 58.82% | |
5mm incision margin of hypopharyngeal carcinoma | 82.35% | |
Hypopharyngeal carcinoma | 86.70% | |
Squamous cell carcinoma of lung (123) | Normal lung tissue | 30.00% |
Paracancerous tissue | 50.00% | |
Squamous cell carcinoma of lung | 75.00% | |
Breast cancer (124) | Paracancerous tissue | 10.00% |
Breast cancer | 87.50% | |
Cervical carcinoma (125) | Chronic cervicitis | 9.50% |
Cervical intraepithelial neoplasia I | 40.00% | |
Cervical intraepithelial neoplasia II-III | 61.30% | |
Invasive carcinoma | 90.50% | |
Nasopharyngeal carcinoma (126) | Chronic inflammatory tissue of nasopharyngeal mucosa | 10.00% |
Advanced nasopharyngeal carcinoma tissue | 66.67% | |
Gastric cancer (127) | Chronic non-atrophic gastritis | 0 |
Chronic atrophic gastritis | 16.70% | |
Low grade intraepithelial neoplasia | 20.00% | |
High grade intraepithelial neoplasia | 59.30% | |
Gastric cancer | 91.80% | |
Renal clear cell carcinoma (128) | Paracancerous tissue | 27.50% |
Renal clear cell carcinoma | 77.50% |
Positive means eIF4E is over expressed, negative means eIF4E is not over expressed.